Trials / Completed
CompletedNCT01272076
Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Carl Zeiss Meditec, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to compare Cirrus HD-OCT automated measurements of the illumination area under the retinal pigment epithelium (RPE) to expert manual measurements of areas of hypofluorescence typical of geographic atrophy in fundus autofluorescence (FAF) images.
Detailed description
Specific Objectives: 1. To compare Cirrus HD-OCT automated measurements of the illumination area under the RPE to expert manual measurements of areas of hypofluorescence typical of geographic atrophy in fundus autofluorescence (FAF) images. 2. To describe the differences and similarities between Cirrus HD-OCT and fundus autofluorescence images of subjects with geographic atrophy secondary to dry age-related macular degeneration (AMD). 3. To determine the clinical factors that affect the Cirrus HD-OCT automated measurements of the illumination area under the RPE.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2011-01-07
- Last updated
- 2014-01-20
- Results posted
- 2013-11-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01272076. Inclusion in this directory is not an endorsement.